Angiographically confirmed stent thrombosis in contemporary practice: Insights from intravascular ultrasound

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 5, 2013, Pages 782-790

  Armstrong, Ehrin J ^a   Kwa, Andrew T ^a   Yeo, Khung Keong ^a   Mahmud, Ehtisham ^b   Javed, Usman ^a   Patel, Mitul ^b   Shunk, Kendrick A ^c,d   MacGregor, John S ^e   Low, Reginald I ^a   Rogers, Jason H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Acute coronary syndrome (ACS) intravascular ultrasound (IVUS) thrombosis (THRM); Intravascular ultrasound; Stent thrombosis

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RECURRENT DISEASE; REGISTER; REVASCULARIZATION; STENT THROMBOSIS; TARGET VESSEL REVASCULARIZATION; AGED; CHI SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY BLOOD VESSEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; EQUIPMENT; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STENT; TREATMENT OUTCOME; UNITED STATES;

AGED; CALIFORNIA; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; CORONARY VESSELS; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84884200787     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24460     Document Type: Article

References (31)

1. van Werkum JW, Heestermans AA, de Korte FI, Kelder JC, Suttorp MJ, et al. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: An analysis of 431 cases. Circulation 2009;119:828-834.
2. Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, et al. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation 2010;122:52-61.
3. Holmes DR Jr, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, Williams DO, Kimura T, Moliterno DJ. Stent thrombosis. J Am Coll Cardiol 2010;56:1357-1365.
4. Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, Satler LF, Canos D, Castagna M, Weissman NJ, Waksman R. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 2003;108:43-47.
5. Alfonso F, Suarez A, Perez-Vizcayno MJ, Moreno R, Escaned J, et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 2007;50:2095-2097.
6. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2005;45:995-998.
7. Liu X, Doi H, Maehara A, Mintz GS, Costa Jde R Jr, et al. A volumetric intravascular ultrasound comparison of early drugeluting stent thrombosis versus restenosis. JACC Cardiovasc Interv 2009;2:428-434.
8. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-2434.
9. Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 2008;29:1851-1857.
10. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
11. Yeo KK, Mahmud E, Armstrong EJ, Bennett WE, Shunk KA, Macgregor JS, Li Z, Low RI, Rogers JH. Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: Results from a multicenter California registry. Catheter Cardiovasc Interv 2012;79:550-556.
12. de Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J 1998;19:1214-1223.
13. Guo N, Maehara A, Mintz GS, He Y, Xu K, et al. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: An intravascular ultrasound substudy of the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial. Circulation 2010;122:1077-1084.
14. Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv 2007;69:387-394.
15. Austin PC. The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making 2009;29:661-677.
16. Lee SW, Park SW, Hong MK, Kim YH, Lee BK, et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol 2005;46:1833-1837.
17. Lee CW, Kang SJ, Park DW, Lee SH, Kim YH, Kim JJ, Park SW, Mintz GS, Park SJ. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010;55:1936-1942.
18. Werner GS, Gastmann O, Ferrari M, Schuenemann S, Knies A, Diedrich J, Kreuzer H. Risk factors for acute and subacute stent thrombosis after high-pressure stent implantation: A study by intracoronary ultrasound. Am Heart J 1998;135(2 Part 1):300-309.
19. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, Fitzgerald PJ, Yock PG. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J 2002;23:124-132.
20. Okabe T, Mintz GS, Buch AN, Roy P, Hong YJ, et al. Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol 2007;100:615-620.
21. de Ribamar Costa J Jr, Mintz GS, Carlier SG, Costa RA, Fujii K, et al. Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. Am J Cardiol 2005;96:74-78.
22. de Ribamar Costa J Jr, Mintz GS, Carlier SG, Fujii K, Sano K, et al. Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J 2007;153:297-303.
23. McCann A, MacIsaac A, Whitbourn RJ. Late drug-eluting stent thrombosis: importance of intravascular ultrasound. Cardiovasc Revasc Med 2010;11:52-56.
24. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009;120:391-399.
25. Hong MK, Mintz GS, Lee CW, Park DW, Lee SW, et al. Impact of late drug-eluting stent malapposition on 3-year clinical events. J Am Coll Cardiol 2007;50:1515-1516.
26. Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: Optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation 2011;123:274-281.
27. Hassan AK, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JW, Schalij MJ, Wouter Jukema J. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 2010;31:1172-1180.
28. Canan T, Lee MS. Drug-eluting stent fracture: incidence, contributing factors, and clinical implications. Catheter Cardiovasc Interv 2010;75:237-245.
29. Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R. Incidence and predictors of drugeluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol 2009;54:1924-1931.
30. Shite J, Matsumoto D, Yokoyama M. Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J 2006;27:1389.
31. Ahmed K, Jeong MH, Chakraborty R, Ahn Y, Sim DS, et al. Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2011;108:8-14.